Liu, Qi
Zhang, Yajuan
Li, Huimin
Gao, Hong
Zhou, Yijie
Luo, Dakui
Shan, Zezhi
Yang, Yufei
Weng, Junyong
Li, Qingguo
Yang, Weiwei
Li, Xinxiang
Funding for this research was provided by:
the Shanghai Science and Technology Development Funds (22QA1409900)
the Shanghai Natural Science Foundation (23ZR1470100, 21ZR1414400)
Shanghai Municipal Science and Technology Major Project
Shanghai Oriental Talent Program
National Natural Science Foundation of China (82103259, 82203520, 81972260)
Shanghai Medical Innovation Research Project (22Y11907600)
CAS Project for Young Scientists in Basic Research (YSBR-014)
the Innovative Research Team of High-level Local Universities in Shanghai (SHSMU-ZLCX20212302)
Article History
Received: 28 January 2024
Accepted: 5 May 2024
First Online: 18 May 2024
Declarations
:
: The use of human CRC specimens was approved by the institutional review board at Fudan University Shanghai Cancer Center (No.050432–4-2108) and complied with all relevant ethical regulations. Informed consents were obtained from all patients. Animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Shanghai Institute of Biochemistry and Cell Biology (SIBCB) and complied with all relevant ethical regulations.
: The authors declare no competing interests.